2495 General Armistead Avenue ● Norristown, Pennsylvania 19403 ● USA ● Tel: +1 (610) 539-3670 ● Fax: +1 (610) 539-3831
(Norristown, Pennsylvania, USA, 4 October 2013) – PluroGen Therapeutics, Inc., a leader in advanced wound care solutions, announced today that it filed another new patent application for its PluroGel® Surfactant Technology Product Line. This new patent application is intended to protect the Company’s flagship PluroGel® Product Line in a multibillion segment of the Advanced Wound Care Market.
Commenting on the new patent filing, PluroGen President & CEO, Neal G. Koller, said “This is another milestone achievement for PluroGen. We now have multiple patent applications filed just for our PluroGel® Surfactant Technology. This new application adds to our Intellectual Property Plan which now maps our protection potential to 2033. Each of these patent applications has the possibility to expand protection for the Company’s business and increases shareholder value. With this filing, the opportunity to have product exclusivity in such a large market segment is very exciting.”
For Immediate Release
4 October 2013
Contact: Tricia Thompson
+1 (610) 539-3670